Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

This resolution states the position of the House of Representatives on drugs used for medication abortion, such as mifepristone. It urges the head of the Food and Drug Administration to reevaluate the safety of all such drugs based on recent independent studies. It also urges the agency to publicly release a full safety review that includes real-world outcomes and complications. The resolution is a statement of the House's views and does not change any law or require the agency to act.

Full text and official record on Congress.gov

Sponsors

• John W. Rose Republican sponsor
• 10 cosponsors